Valsartan Tablets USP 160 mg, 100 Tablets (10 x 10) per Unit Dose Blisters, Rx O Supply Disruption — American Health Packaging (Mo
Valsartan Tablets USP 160 mg, 100 Tablets (10 x 10) per Unit Dose Blisters, Rx O Supply Disruption — American Health Packaging (Mo is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: Valsartan Tablets USP 160 mg, 100 Tablets (10 x 10) per Unit Dose Blisters, Rx O; Manufacturer: Ameri
| Drug name | Valsartan Tablets USP 160 mg, 100 Tablets (10 x 10) per Unit Dose Blisters, Rx O |
|---|---|
| Manufacturer | American Health Packaging |
| Recall/Disruption reason | CGMP Deviation: Presence of NDEA (N-Nitrosodimethylamine), a carcinogen impurity, detected in the active ingredient. |
| Risk classification | Moderate Risk — Temporary Health Consequence |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-1047-2019 |
| Initiation date | 20190306 |
| Quantity affected | 3337 cartons |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →